Abarca Prize | |
---|---|
Doctor Juan Abarca International Award for Medical Sciences | |
![]() | |
Awarded for | Biomedical research of global significance |
Sponsored by | Fundación de Investigación HM Hospitales |
Country | Spain |
Reward(s) | 100,000 € |
Established | 2021 |
Website | https://www.abarcaprize.com/ |
The Doctor Juan Abarca International Award in Medical Sciences, known as the Abarca Prize, is an award that recognises research and innovation through a biomedical finding of global significance. [1] [2]
Created in 2020 by the Fundación de Investigación HM Hospitales, it is awarded to the scientific or medical career of a person who has made a significant contribution to the protection, improvement or rehabilitation of people's health. [3]
The award, endowed with 100,000 euros, [4] is inspired by the Spanish surgeon Juan Abarca Campal, founder of HM Hospitales. [5] The jury, appointed by the Fundación de Investigación HM Hospitales, is made up of members of the scientific community.
The first edition of the award was held in October 2021. The award ceremony was chaired by King Felipe VI. [6] The jury was headed by Alberto Muñoz, professor at the Instituto de Investigaciones Biomédicas de Madrid (IIBM) and included Richard Horton, editor of The Lancet, Silvia G. Priori, scientific director of the ICS Maugeri Hospital, [7] palaeoanthropologist Juan Luis Arsuaga, and Federico de Montalvo, former president of the Spanish Bioethics Committee. The Abarca Prize was awarded to Professor Jean-Laurent Casanova for his findings in the field of human infections and the genetic variations that affect a person's ability to fight them. [2] Dr. Casanova is a researcher at Rockefeller University Hospital in New York and director of the St. Giles Laboratory of Human Genetics and Infectious Diseases.
In 2022 the prize was awarded to Professor Philippe J. Sansonetti of the Pasteur Institute for his research on Shigellosis or bacillary dysentery. [8] This diarrheal disease caused by the bacterium Shigella causes thousands of deaths annually in developed countries, mainly affecting children. [9] The jury was composed of Professors Juan Luis Arsuaga, Silvia Priori, Jean-Laurent Casanova and Federico de Montalvo, and was chaired by Professor Alberto Muñoz, from the Institute of Biomedical Research of Madrid (IIB- CSIC). [10] The award was presented by the Spanish Secretary of State for Health, Silvia Calzón. [11]
Professor Douglas A. Melton, won the III Abarca Prize in its 2023 call, for his advances towards a cure for diabetes. [12] Douglas A. Melton is co-director of the Harvard Stem Cell Institute, a Howard Hughes Institute of Medicine investigator and an investigator at Vertex Pharmaceuticals. [13]
Melton's research has pioneered the process of converting stem cells into insulin-producing beta cells, which would enable cell replacement therapy for type 1 diabetes. [13] The award was presented by the Spanish Minister of Health, José Miñones. [14]
The immunologist Carl H. June, director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, was awarded the fourth prize for the discovery of a revolutionary therapy for treating blood cancers based on cellular engineering. [15] The CAR-T (chimeric antigen receptor) cell therapy harnesses the body's own immune system to fight cancer. [16] Carl H. June is the Richard W. Vague Professor of Immunotherapy at the Vague School of Medicine at the University of Pennsylvania. In 2024, his scientific team is working to apply this treatment to other solid neoplasms, autoimmune diseases (such as lupus) and other non-oncological diseases. [17] The jury for the 4th edition was made up of Professors Silvia Priori, who chaired the jury, Philippe J. Sansonetti, Pura Muñoz-Cánoves, Sandra Myrna Diaz, Federico de Montalvo, Juan Luis Arsuaga and the winner of the 2023 call, Professor Douglas A. Melton. [18] Dr June was received by King Felipe VI after the award ceremony, together with Juan Abarca Cidón, President of HM Hospitales, Elena Abarca Cidón, Vice-President of HM Hospitales, and Alberto Muñoz Terol, President of the HM Hospitales Research Foundation. [19]
Edition | Year | Winners | Scientific contribution |
---|---|---|---|
I Edition | 2021 | Jean-Laurent Casanova | Insights into human infections and their genetic control |
II Edition | 2022 | Philippe J. Sansonetti | Research on shigellosis or bacillary dysentery |
III Edition | 2023 | Douglas A. Melton | Advances in diabetes care |
IV Edition | 2024 | Carl H. June | CAR-T cell therapy for the treatment of blood cancers |
Juan Luis Arsuaga Ferreras is a Spanish paleoanthropologist and author known for his work in the Atapuerca Archaeological Site.
The Central University of Venezuela is a public university located in Caracas, Venezuela. Founded in 1721, it is the oldest university in Venezuela and one of the oldest in the Western Hemisphere.
Fernando Ramón Martínez Heredia was a prominent Cuban revolutionary thinker and politician. Martínez was a founding member of the Cuban Communist Party, and as a member of the July 26 Movement, he took part in the Revolution which overthrow the Batista dictatorship.
Adela Cortina is a Spanish philosopher.
The Last Train is a 2002 Uruguayan and Argentine, comedy drama film, directed by Diego Arsuaga, and written by Arsuaga, Fernando León de Aranoa, and Beda Docampo Feijóo. It's also known as Corazón de fuego in Argentina.
Ramón Zaydín y Márquez Sterling (1895–1968) was a Cuban politician and Prime Minister of Cuba.
Philippe J. Sansonetti is a French microbiologist, professor at the Pasteur Institute and the Collège de France in Paris. He is the director of the Inserm Unit 786 and of the Institut Pasteur laboratory Pathogénie Microbienne Moléculaire.
The National Institute of Health Sciences and Nutrition "Salvador Zubirán" is one of the twelve national institutes part of the Mexican Secretariat of Health. Its main functions and services include medical research, specialized medical attention and health education for future professionals. It is located in the Tlalpan borough in the south of Mexico City where the main hospitals in the city are located. David Kershenobich Stalnikowitz currently manages the institute.
Primarosa Rinaldi de Chieri is an Argentine-Italian geneticist and physician. In 1965, she obtained her medical degree, from the Faculty of Medicine at the University of Buenos Aires. In 1978, she received a doctorate from the same university. She is a consultant and lecturer in genetics and serves as First Chair at the pediatrics department of UBA. She is also a director of the laboratory of genetic analysis at Primagen.
Ortún Velázquez de Velasco was a Spanish conquistador. He is known as the co-founder and first governor of Pamplona in the Norte de Santander department of Colombia, which borders Venezuela.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Fermín Caballero y Morgáez was a Spanish geographer, journalist, writer, and liberal politician.
Nubia Muñoz is a Colombian medical scientist and epidemiologist, whose research has been instrumental in establishing that human papillomavirus (HPV) infection is the primary cause of cervical cancer which has led to the development of a vaccine that is capable of preventing 70% of all cervical cancers.
Xavier Ros Oton is a Spanish mathematician who works on partial differential equations (PDEs). He is an ICREA Research Professor and a Full Professor at the University of Barcelona.
Alberto Sols García (1917–1989) was a Spanish researcher specializing in biochemistry, working especially on hexokinases. He effectively created biochemistry as a major discipline in Spain.
Antonio Alarco Hernandez is a Spanish politician, surgeon and professor. He was elected into the senate of Spain since 2008 representing Tenerife under the People's Party (Spain). He has served on the 9th, 10th, 11th, 12th, 13th and 14th Cortes Generales of Spain. He is a professor of Surgery at the University of La Laguna and a physician.
The Faculty of Medical Sciences, formerly and commonly known as the Faculty of Medicine, is the medical school of the University of Buenos Aires (UBA), the largest university in Argentina. Established in 1822 as one of the UBA's earliest divisions, FMED is presently the largest medical school in Argentina, with over 24,000 enrolled students as of 2011.
Juan Abarca Campal is a Spanish physician and surgeon, businessman and founder of the HM Hospitales group.
HM Hospitales is a private Spanish hospital group with a presence in the autonomous communities of Madrid, Galicia, Catalonia, Andalusia, Castilla-León and Castilla-La Mancha. It has 48 healthcare centers. Since 2008, the hospitals in the Community of Madrid have been university hospitals carrying out research and teaching.
Juan Abarca Cidón is a Spanish doctor, lawyer, and businessman. He is president of the HM Hospitales Group and of Profesionales de la Medicina y el Derecho (PROMEDE), an expert witness company. He is an advocate of the private health care model, and part of the political debate on public and private healthcare.